v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 26, 2026
Sep. 27, 2025
Cash flows relating to operating activities    
Net income $ 318,882 $ 134,127
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 206,701 325,035
Long-lived asset impairments 27,171 36,185
Stock-based compensation 62,929 53,451
Deferred income taxes (4,089) (15,122)
Reversal of an unrecognized tax benefit reserve and related interest and penalties (245,638) 0
Write down of inventories 4,033 10,697
(Gains) losses and impairments on venture capital and strategic equity investments, net (4,897) 33,955
(Gain) loss on sale of assets (37,776) 982
Provision for credit losses 1,935 4,559
(Gain) loss on divestitures, net 180,300 (3,376)
Other, net (8,538) 2,324
Changes in assets and liabilities:    
Trade receivables and contract assets, net (110,271) 8,106
Inventories 64,440 (45,280)
Accounts payable 25,601 40,747
Accrued compensation (26,898) 81,870
Deferred revenue 6,227 (12,319)
Customer contract deposits 12,681 (533)
Other assets and liabilities, net 2,094 (65,282)
Net cash provided by operating activities 474,887 590,126
Cash flows relating to investing activities    
Acquisition of businesses and assets, net of cash acquired (467,254) 0
Capital expenditures (133,823) (130,202)
Purchases of investments and contributions to venture capital investments (14,718) (12,544)
Proceeds from sale of investments 18,876 5,637
Proceeds from surrender of life insurance policies 58,127 0
Proceeds from sale of businesses and assets, net 176,563 17,441
Other, net (7,292) 3,154
Net cash used in investing activities (369,521) (116,514)
Cash flows relating to financing activities    
Proceeds from long-term debt and revolving credit facility 1,420,223 1,070,861
Payments on long-term debt, revolving credit facility, and finance lease obligations (1,081,266) (1,141,500)
Proceeds from exercises of stock options 29,733 3
Purchase of treasury stock (324,105) (360,577)
Payment of contingent consideration and deferred acquisition consideration (111,394) (21,822)
Purchase of remaining equity interests of other redeemable noncontrolling interest 0 (19,140)
Other, net (4,274) (12,687)
Net cash used in financing activities (71,083) (484,862)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (1,199) 14,900
Net change in cash, cash equivalents, and restricted cash 33,084 3,650
Cash, cash equivalents, and restricted cash, beginning of period 215,997 205,570
Cash, cash equivalents, and restricted cash, end of period $ 249,081 $ 209,220